Balkan Journal of Medical Genetics

VITAMIN D RECEPTOR POLYMORPHISMS AMONG THE TURKISH POPULATION ARE ASSOCIATED WITH MULTIPLE SCLEROSIS
Bulan B1, Hoscan AY1, Keskin SN1, Cavus A1, Culcu EA1, Isik N2, List EO2, Arman A*4
*Corresponding Author: Dr. Ahmet Arman, The Department of Medical Genetics, Marmara Teaching and Research Hospital, Marmara University, 34899, Pendik, Istanbul/TURKEY. Tel #: +90-216- 657 0606, Fax #: +90-216-414 47 31, e-mail: ahmetarman@marmara.edu.tr, ORCID Id: https://orcid.org/0000-0001-5547-0024
page: 10

REFERENCES

1. Kalman B, Toldy E. Genomic binding sites and biological effects of the vitamin D--VDR complex in multiple sclerosis. Neuromolecular Med. 2014; 16(2): 265-79. 2. Librau RS, Singer SM, McDevitt HO. Th1 and Th2 CD41 T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today. 1995; 16: 34–48. 3. Hasheminia SJ, Tolouei S, Zarkesh-Esfahani SH, Shaygannejad V, Shirzad HA, Torabi R, Hashem Zadeh Chaloshtory M. Cytokines gene expression in newly diagnosed multiple sclerosis patients. Iran J Allergy Asthma Immunol. 2015; 14(2): 208-16. 4. Brück W. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. J Neurol. 2005; 252(5):v3–9. 5. García-Martín E, Agúndez JA, Martínez C, Benito- León J, Millán-Pascual J, Calleja P, et al. Vitamin D3 receptor (VDR ) gene rs2228570 (Fok1) and rs731236 (Taq1) variants are not associated with the risk for multiple sclerosis: results of a new study and a meta-analysis. PLoS One. 2013; 8(6): e65487. 6. Herrero-Herranz E, Pardo LA, Gold R, Linker RA. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neurobiol Dis. 2008; 30: 162–73. 7. Huang J, Xie Z. Polymorphisms in the vitamin D receptor gene and multiple sclerosis risk: A metaanalysis of case–control studies, Journal of the Neurological Sciences. 2012; 313: 79–85. 8. Goldenberg MM. Multiple sclerosis review. P & T. 2012; 37(3): 175–84. 9. Kurland LT. The frequency and geographic distribution of multiple sclerosis as indicated by mortality statistics and morbidity surveys in the United States and Canada. Amer. J. Hygiene. 1952; 55: 457–76. 10. Pugliatti M, Harbo HF, Holmøy T, Kampman MT, Myhr KM, et al. Environmental risk factors in multiple sclerosis. Acta Neurol Scand Suppl. 2008; 188: 34–40. 11. Martina B. Sintzel . Mark Rametta . Anthony T. Reder. Vitamin D and Multiple Sclerosis: A Comprehensive Review. Neurol Ther. 2018; 7: 59–85. 12. Ebers GC, Kukay K, Bulmann DE, et al. A full genome search in multiple sclerosis. Nat Genet. 1996; 13: 472–6. 13. Sawcer S, Jones HB, Feakes R, et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosomes 6p21 and 17q22. Nat Genet. 1996; 13: 464–8. 14. Fukazawaa T, Yabeb I, Kikuchib S, Sasakib H, Hamadaa T, Miyasaka K, et al. Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. Journal of the Neurological Sciences. 1999; 166: 47–52. 15. Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, Dyment DA et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA–DRB1*1501 is regulated by vitamin D. PloS Genet. 2009; 5: e1000369. 16. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Rheumatic Disease Clinics of North America. 2012; 38(1): 125–39. 17. Jurutka PW, Bartik L, Whitfield GK, et al. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. Journal of Bone and Mineral Research. 2007; 22(2): v2-10. 18. Lemire JM, Archer DC. 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest. 1991; 87: 1103–7. 19. Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA. 1996; 93: 7861–4. 20. Meehan TF, DeLuca HF. The vitamin D receptor is necessary for 1𝛼,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice. Archives of Biochemistry and Biophysics. 2002; 408(2): 200–4. 21. Narooie-Nejad M, Moossavi M, Torkamanzehi A, Moghtaderi A. Positive Association of Vitamin D Receptor Gene Variations with Multiple Sclerosis in South East Iranian Population. Hindawi Publishing Corporation BioMed Research International. 2015; Article ID 427519: 1-4. 22. Simon K, Munger K, Yang X, Ascherio A. Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Multiple Sclerosis. 2010; 16(2): 133–8. 23. Cox MB, Ban M, Bowden NA, Baker A, Scott RJ, Lechner-Scott J. Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis. Mult Scler. 2012; 18(1): 16-22. 24. Niino M, Fukazawa T, Yabe I, Kikuchi S, Sasaki H, Tashiro K. Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles. Journal of the Neurological Sciences. 2000; 177(1): 65–71. 25. Tajouri L, Ovcaric M, Curtain R, et al. Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population. J Neurogenet. 2005; 19(1): 25–38. 26. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338: 143–56. 27. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS: Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001, 50: 121-127. 28. Nasiri H, Forouzandeh M, Rasaee MJ and Rahbarizadeh F. Modified salting-out method: High-yield, high-quality genomic DNA extraction from whole blood using laundry detergent. J Clin Lab Anal. 2005; 19(6): 229-32. 29. Smolders J, Peelen E, Thewissen M, Menheere P, Tervaert J, Hupperts R, Damoiseaux J. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmunity Reviews. 2009; 8: 621–6. 30. Mamutse G, Woolmore J, Pye E, Partridge J, Boggild M, Young C, et al. Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis. Mult Scler. 2008; 14: 1280–3. 31. Dickinson JL, Perera DI, van der Mei AF, Ponsonby AL, Polanowski AM, Thomson RJ, et al. Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction. Mult Scler. 2009; 15: 563–70. 32. Partridge JM, Weatherby SJ, Woolmore JA, Highland DJ, Fryer AA, Mann CL, et al. Susceptibility and outcome in MS: associations with polymorphisms in pigmentation-related genes. Neurology. 2004; 62: 2323–5. 33. Ozden Kamisli, Ceren Acar, Mert Sozen, Mehmet Tecellioglu, Fatma Ebru Yücel, Dilara Vaizoglu et al. The association between vitamin D receptor polymorphisms and multiple sclerosis in a Turkish population: Multiple Sclerosis and Related Disorders. 2018; 20: 78-81. 34. Danyal Imani, Bahman Razi, Morteza Motallebnezhad, Ramazan Rezaei. Association between vitamin D receptor(VDR) polymorphisms and the risk of multiple sclerosis (MS): an updated meta-analysis. Imani et al. BMC Neurology. 2019; (19): 339. 35. Orton SM, Ramagopalan SV, Para AE, Lincoln MR, Handunnetthi L, Chao MJ et al. Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians. J Neurol Sci. 2011; 305(1-2): 116-20.

Number 27 VOL. 27 (1), 2024	Number 26 Number 26 VOL. 26(2), 2023 All in one
Number 26 VOL. 26(2), 2023	Number 26 VOL. 26, 2023 Supplement
Number 26 VOL. 26(1), 2023	Number 25 VOL. 25(2), 2022
Number 25 VOL. 25 (1), 2022	Number 24 VOL. 24(2), 2021
Number 24 VOL. 24(1), 2021	Number 23 VOL. 23(2), 2020
Number 22 VOL. 22(2), 2019	Number 22 VOL. 22(1), 2019
Number 22 VOL. 22, 2019 Supplement	Number 21 VOL. 21(2), 2018
Number 21 VOL. 21 (1), 2018	Number 21 VOL. 21, 2018 Supplement
Number 20 VOL. 20 (2), 2017	Number 20 VOL. 20 (1), 2017
Number 19 VOL. 19 (2), 2016	Number 19 VOL. 19 (1), 2016
Number 18 VOL. 18 (2), 2015	Number 18 VOL. 18 (1), 2015
Number 17 VOL. 17 (2), 2014	Number 17 VOL. 17 (1), 2014
Number 16 VOL. 16 (2), 2013	Number 16 VOL. 16 (1), 2013
Number 15 VOL. 15 (2), 2012	Number 15 VOL. 15, 2012 Supplement
Number 15 Vol. 15 (1), 2012	Number 14 14 - Vol. 14 (2), 2011
Number 14 The 9th Balkan Congress of Medical Genetics	Number 14 14 - Vol. 14 (1), 2011
Number 13 Vol. 13 (2), 2010	Number 13 Vol.13 (1), 2010
Number 12 Vol.12 (2), 2009	Number 12 Vol.12 (1), 2009
Number 11 Vol.11 (2),2008	Number 11 Vol.11 (1),2008
Number 10 Vol.10 (2), 2007	Number 10 10 (1),2007
Number 9 1&2, 2006	Number 9 3&4, 2006
Number 8 1&2, 2005	Number 8 3&4, 2004
Number 7 1&2, 2004	Number 6 3&4, 2003
Number 6 1&2, 2003	Number 5 3&4, 2002
Number 5 1&2, 2002	Number 4 Vol.3 (4), 2000
Number 4 Vol.2 (4), 1999	Number 4 Vol.1 (4), 1998
Number 4 3&4, 2001	Number 4 1&2, 2001
Number 3 Vol.3 (3), 2000	Number 3 Vol.2 (3), 1999
Number 3 Vol.1 (3), 1998	Number 2 Vol.3(2), 2000
Number 2 Vol.1 (2), 1998	Number 2 Vol.2 (2), 1999
Number 1 Vol.3 (1), 2000	Number 1 Vol.2 (1), 1999
Number 1 Vol.1 (1), 1998

About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact